Anti-cancer composition for delivering 5-fluorouracil
US4622325A · kind A · utility
3Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 1984 |
| Grant date | Nov 11, 1986 |
| Priority date | — |
| Expiry date | Mar 20, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-cancer composition for delivering 5-fluorouracil to cancer tissues in a warm-blooded animal, wherein the cancer is a cancer sensitive to 5-fluorouracil, comprising 1-n-hexylcarbamoyl-5-fluorouracil and uracil (or salt there-of), wherein the composition contains less than 0.1 mole of the 5-fluorouracil per mole of the uracil.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.